2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$13.70+$0.03 (+0.22%)
Price as of Jun 23, 2026 4:10 PM EDT- $610.5MMarket Cap
- -13.29%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$13.70+$0.03 (+0.22%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.67 | ||
Change | -$0.18 (-1.30%) | ||
Open | $13.67 | ||
High | $13.94 | ||
Low | $13.50 | ||
Previous Close | $13.70 | ||
Volume | 864,205 | ||
30-Day Average Volume | 977,009 | ||
1-Week Change | -4.73% | ||
1-Month Change | 15.91% | ||
1-Year Change | -13.29% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 44.6M | ||
Total Assets | $304.4M | ||
Market Cap | $610.5M | ||
Enterprise Value | $580.3M | ||
Period: QTR TTM FY | |||
Revenue | $27.6M | ||
Net Income | -$21.9M | ||
Free Cash Flow | -$25.2M | ||
EBIT | -$21.9M | ||
EBITDA | -$21.3M | ||
Net Working Capital | $224.8M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 2 | ||
P/E | -28 | ||
PEG | 0 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue